How often should regulatory monitoring happen?
Regulatory monitoring should happen often enough that teams can act before the decision window closes. For high-risk substances, active markets, or fast-moving regimes, that usually means continuous or near-continuous monitoring. Lower-risk areas may be reviewed on a scheduled cadence, but the rationale should be explicit.
Published
Cadence follows risk
A team tracking a substance under active restriction pressure needs a different cadence from a team watching a mature rule with stable guidance.
The right question is not how often monitoring feels reasonable. It is how much time the business needs to respond once an early signal appears.
Late signals are expensive
Late detection can compress reformulation, customer communication, supplier qualification, labelling work, and leadership decision-making into the same window.
The practical value of more frequent monitoring is often the time it gives teams to think instead of fire-fighting.
See also. Readiness assessment
